Our therapeutics pipeline includes cancer drug compounds such as QN-247 (formerly referred to as AS1411-GNP or ALAN), and RAS-F, as well as STARS, a DNA/RNA-based treatment device.

To learn more about partnering or licensing opportunities, please contact partnering@qualigeninc.com

Select a drug candidate to learn more